Novartis Gains FDA Approval For Amturnide™, A Triple-Combination Pill To Treat High Blood Pressure In Patients Uncontrolled On Two Medications
Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ)... (Source: Health News from Medical News Today)
Well Blog: Parents, Coaches and Youth Sports
Outspoken parents may be keeping good coaches away from youth sports. (Source: NYT Health)